Medicines Co's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Medicines Co's ROA in the third quarter of 2019?
Medicines Co recorded a cumulative net loss of $-236 million during 12 months ending in the third quarter of 2019, resulting in a negative return on assets (ROA) of -26.78%.

However, within the Healthcare sector 368 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2019 quarter, so far to 3956, from total ROA ranking in the second quarter of 2019 at 3988.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter
Y / Y Total Assets Change	22.29 %	20.16 %	-2.94 %	-3.59 %	-27.13 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-236	-218	-212	-123	-259
Return On Assets (TTM)	-26.78 %	-25.9 %	-26.46 %	-15.24 %	-31.74 %
MDCO's Total Ranking	# 3956	# 3988	# 4050	# 4240	# 4082
Total Assets (TTM) in million	897	956	836	842	734
Seq. Total Assets Change	-6.17 %	14.41 %	-0.69 %	14.71 %	-7.8 %
Seq. Net Income Change	-	-	-	-	-

MDCO's 5 Years Annual ROA >> Back to MDCO Management Effectiveness >> Compare MDCO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 140
Sector	# 369
Overall	# 3795

Return On Assets Statistics
High	Average	Low
30.89 %	-8.75 %	-61.3 %
(Sep 30 2011)		(Dec 31 2017)

Financial Statements
Medicines Co's Assets	$ 897 million	MDCO's Balance sheet
Medicines Co's Income	$ -74 million	Quarterly MDCO's Income Statement
MDCO's Income by Division		See MDCO's Income by Division

Annual Return On Assets	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016	(Dec 31 2015) FY 2015	(Dec 31 2014) FY 2014
Y / Y Total Assets Change	-3.59 %	-48.8 %	-5.63 %	-4.18 %	8.29 %
Total Assets in million	842	873	1,705	1,807	1,886
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-123	-708	-119	-353	-32
Annual Return On Assets	-14.63 %	-81.14 %	-6.99 %	-19.52 %	-1.71 %

MDCO's 5 Years Annual ROA >> Back to MDCO Management Effectiveness >> Compare MDCO ROA to its Competitors

More Return On Assets Ratios
MDCO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MDCO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MDCO's Competitors
Subscribers only: Roa for Medicines Co's Suppliers
Subscribers only: Return On Assets for MDCO's Customers

You may also want to know
MDCO's Roi	MDCO's Inventory Turnover Ratio	MDCO's Growth Rates	MDCO's Dividend Comparisons
	MDCO's Profitability Ratios	MDCO's Asset Turnover Ratio	MDCO's Dividend Growth
MDCO's Roe	MDCO's Valuation Ratios	MDCO's Financial Strength Ratios	MDCO's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:09:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.